Related Experiment Video
Updated: Nov 9, 2025

Differentiation of Human Pluripotent Stem Cells into Insulin-Producing Islet Clusters
Published on: June 23, 2023
Human pluripotent stem cell-derived insulin-producing cells: A regenerative medicine perspective
Adriana Migliorini1, Maria Cristina Nostro2, Julie B Sneddon3
1McEwen Stem Cell Institute, University Health Network, Toronto, ON M5G 1L7, Canada.
Abstract:
Tremendous progress has been made over the last two decades in the field of pancreatic beta cell replacement therapy as a curative measure for diabetes. Transplantation studies have demonstrated therapeutic efficacy, and cGMP-grade cell products are currently being deployed for the first time in human clinical trials. In this perspective, we discuss current challenges surrounding the generation, delivery, and engraftment of stem cell-derived islet-like cells, along with strategies to induce durable tolerance to grafted cells, with an eye toward a functional cellular-based therapy enabling insulin independence for patients with diabetes.
More Related Videos
Related Concept Videos
iPS Cell Differentiation
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic...
EPS and iPS Cells in Disease Research
Stem Cell Culture
Embryonic Stem Cells

